Cleveland Clinic Ovarian Cancer Vaccine Innovation Issued European Patent

Retrieved on: 2021-03-13 17:15:00

Tags for this article:

Click the tags to see associated articles and topics

Cleveland Clinic Ovarian Cancer Vaccine Innovation Issued European Patent. View article details on hiswai:

Excerpt

'By developing vaccines that target alpha-lactalbumin and AMHR2-ED, we feel the immune system can destroy breast cancer cells and ovarian cancer ...

Article found on: www.precisionvaccinations.com